Unlock instant, AI-driven research and patent intelligence for your innovation.

Polyvalent RNA-nanoparticle composition

A technology of nanoparticles and compositions, applied in the field of nanoparticles, can solve problems such as inability to establish experimental reactions

Inactive Publication Date: 2017-07-18
NORTHWESTERN UNIV
View PDF129 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This protein is essential for mouse development, and cells lacking Argonaute2 fail to mount experimental responses to siRNA

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Polyvalent RNA-nanoparticle composition
  • Polyvalent RNA-nanoparticle composition
  • Polyvalent RNA-nanoparticle composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0139] Example 1. Preparation of RNase-free nanoparticles

[0140] Citrate-stabilized gold nanoparticles (13 nm) were prepared using a published method [Frens, Nature Physical Science 241:20-22 (1973)]. After synthesis, the particles were treated with 0.1% diethylpyrocarbonate (DEPC) for 12 hours with stirring and then autoclaved at 121° C. for 60 minutes. Importantly and rather surprisingly, the optical and physical properties of the nanoparticles were not affected by this relatively extreme treatment, as can be analyzed by UV spectroscopy and TEM ( figure 1 )Measurement. Subsequent ligand functionalization was also unaffected by this treatment. Detection of RNase activity in these solutions using the RNaseAlert kit (Ambion) showed no detectable RNase activity compared to control or untreated particles ( figure 2 ).

Embodiment 2

[0141] Example 2. Modification of RNase-free nanoparticles

[0142] The resulting RNase-free nanoparticles were further appropriately modified by thiolated oligonucleotides using published procedures [Demers et al., Anal. Chem. 72:5535 (2000)]. Subsequent functionalization with RNA could not be achieved without this pretreatment, presumably due to rapid degradation of the RNA-based surface capping ligand. A duplex consisting of a 27-base RNA strand and a 25-base complement terminated with an ethylene glycol spacer and an alkylthiol was hybridized and added to RNase-free Au NPs , which allow them to be absorbed chemically via thiol-gold bonds. For this work, the sequence was designed to target the firefly luciferase gene.

[0143] RNA oligonucleotides were synthesized using TOM-RNA reagents (Glen Research) and MerMade 6 (Bioautomation), or were prepared commercially (Integrated DNA Technologies). Oligonucleotides synthesized from non-commercial sources were purified using th...

Embodiment 3

[0148] Example 3. Cellular uptake of RNA-nanoparticle compositions

[0149] Using the fluorescent (cyanine 5, Cy5) compositions prepared above, the ability of the compositions to enter cells was studied by confocal microscopy. RNA-Au NPs were added to cultures of HeLa cells. Cells were grown on glass coverslips and treated with nanoparticles functionalized with fluorophore-labeled RNA duplexes. After 6 hours of treatment, coverslips were removed, washed with PBS, and mounted in slide-mounted chambers filled with PBS. All images were acquired by a scanning confocal microscope (Zeiss 510LSM) at 63x magnification and a 633 nm HeNe laser excitation source. Imaging studies showed fluorescence in all HeLa cells after 6 hours ( Figure 4 a). It is interesting to note that, like DNA Au-NPs, RNA Au-NPs do not require transfection agents to enter cells [Giljohann et al., Nano Lett. 7:3818 (2007)]. Indeed, analytical flow cytometry confirmed RNA-Au NP uptake in >99% of the cell popu...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
Login to View More

Abstract

Polyvalent RNA-nanoparticle composition is provided. The present invention concerns nanoparticles functionalized with duplex RNA for a variety of uses, including but not limited to gene regulation. More specifically, the disclosure provides a new strategy for conjugating RNA to a nanoparticle to achieve increased stability and activity.

Description

[0001] Case Description [0002] This application is a divisional application of an invention patent application with a filing date of November 24, 2009, a national application number of 200980146985.6, and an invention title of "multivalent RNA nanoparticle composition". [0003] Statement of Government Interest [0004] According to the grant number 5U54CA119341 awarded by the National Cancer Institute / Centers of Cancer Nanotechnology Excellence (NCF / CCNE) and the grant number 5DPl OD000285 awarded by the National Institutes of Health (NIH), This application was made with government support. technical field [0005] The present invention relates to nanoparticles functionalized with double-stranded RNA. The invention also provides methods of conjugating RNA to nanoparticles. Background technique [0006] RNA interference (RNAi) is a phenomenon in which, when double-stranded RNA (dsRNA) is present in a cell, it inhibits the expression of a gene having a sequence sufficien...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K47/69A61K31/713C12N15/11A61P35/00
CPCA61K31/713A61K48/00C12N15/111C12N2310/14C12N2310/351C12N2320/32A61K9/51A61K47/6923A61P19/02A61P29/00A61P31/12A61P35/00A61P43/00C12N15/1137C12N2310/531
Inventor 查德·A·米尔金大卫·A·吉拉约翰德怀特·塞费罗斯安德鲁·E·普里戈迪奇皮尼亚尔·C·帕特尔
Owner NORTHWESTERN UNIV